FDA advisers back Seroquel XR for depression, but not anxiety

04/8/2009 | Reuters

An FDA panel ruled that Seroquel XR is safe to use in combination with other drugs to treat certain patients with depression, bolstering AstraZeneca's bid to increase uses of the schizophrenia medicine. The advisers did not recommend the product for treating anxiety because of its link to serious adverse effects.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT